Spinal Clinical Trials in Chicago, Illinois
25 recruitingChicago, Illinois
Showing 1–20 of 25 trials
Recruiting
Phase 2
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Spinal Muscular Atrophy (SMA)
argenx60 enrolled17 locationsNCT07287982
Recruiting
Not Applicable
Cortical Recording and Stimulating Array Brain-Machine Interface
Spinal Cord InjuryBrainstem StrokeBrachial Plexus Injury+2 more
Michael Boninger30 enrolled2 locationsNCT01894802
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
Stryker Instruments8,000 enrolled2284 locationsNCT03072927
Recruiting
Not Applicable
Improving Adherence to Spinal Cord Injury Exercise Guidelines Using Smartphone Technology and E-coaching
Spinal Cord Injuries
Shirley Ryan AbilityLab50 enrolled1 locationNCT05424172
Recruiting
Not Applicable
Nomad P-KAFO Study
Multiple SclerosisSpinal Cord InjuriesCerebrovascular Accident+3 more
Shirley Ryan AbilityLab36 enrolled1 locationNCT05644522
Recruiting
Phase 4
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
Muscular Atrophy, Spinal
Hoffmann-La Roche28 enrolled16 locationsNCT05861986
Recruiting
Not Applicable
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Spinal Muscular AtrophyScoliosisSpine Deformity
Alcyone Therapeutics, Inc90 enrolled21 locationsNCT05866419
Recruiting
Not Applicable
Combination Therapy to Improve SCI Recovery.
Spinal Cord Injuries
Spaulding Rehabilitation Hospital60 enrolled2 locationsNCT05563103
Recruiting
Phase 1
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
Muscular Atrophy, Spinal
Biogen58 enrolled19 locationsNCT06555419
Recruiting
Phase 1Phase 2
NVG-291 in Spinal Cord Injury Subjects
chronic spinal cord injurySpinal Cord InjuriesSubacute Spinal Cord Injury
NervGen Pharma40 enrolled1 locationNCT05965700
Recruiting
Not Applicable
Promoting Recovery Outcomes Through Precise Early Locomotor Interventions in Persons With Spinal Cord Injury
Spinal Cord Injuries
Milap Sandhu108 enrolled2 locationsNCT06176833
Recruiting
Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery
ScoliosisSagittal ImbalanceAdult Spinal Deformity+1 more
International Spine Study Group Foundation500 enrolled12 locationsNCT04885244
Recruiting
Phase 4
Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery
Lumbar RadiculopathyDegenerative Disc DiseaseLumbar Spinal Stenosis+7 more
John O'Toole125 enrolled1 locationNCT05029726
Recruiting
Not Applicable
Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational Interviewing
Spinal Cord Injuries (SCI)Spinal Cord Disease
Shirley Ryan AbilityLab180 enrolled3 locationsNCT07364773
Recruiting
Not Applicable
Spinal Cord Stimulation for Functional Recovery in Humans With Tetraplegia
Spinal Cord Injury
VA Office of Research and Development86 enrolled2 locationsNCT05157282
Recruiting
The Myelin Disorders Biorepository Project
AdrenoleukodystrophyCockayne SyndromeRefsum Disease+63 more
Children's Hospital of Philadelphia12,000 enrolled23 locationsNCT03047369
Recruiting
Not Applicable
Improve Dynamic Lateral Balance of Humans With SCI
Spinal Cord Injury
Shirley Ryan AbilityLab54 enrolled1 locationNCT02991248
Recruiting
Not Applicable
Human-like Robotic Controllers for Enhanced Motor Learning
StrokeSpinal Cord Injuries
Shirley Ryan AbilityLab764 enrolled1 locationNCT04578665
Recruiting
Phase 1Phase 2
Double Dose 4-AP on Functional Recovery After Spinal Cord Injury
SCI - Spinal Cord Injury
Shirley Ryan AbilityLab27 enrolled1 locationNCT06853015
Recruiting
Phase 2
Study of Olutasidenib and Temozolomide in HGG
Metastatic Brain TumorIDH1 MutationAstrocytoma, Grade IV+16 more
Rigel Pharmaceuticals60 enrolled18 locationsNCT06161974